Literature DB >> 7554376

HCV infection in patients with primary defects of immunoglobulin production.

I Quinti1, F Pandolfi, R Paganelli, D el Salman, A Giovannetti, R Rosso, A Oliva, L Rainaldi, F Aiuti.   

Abstract

We tested for infection with hepatitis C virus (HCV) in 58 patients affected by humoral immunodeficiencies: 43 common variable immunodeficiency (CVI), two hyper IgM syndrome (HIM), two IgG subclass deficiency, four ataxia-telangiectasia (AT), and seven X-linked agammaglobulinaemia (XLA). While the assessment of serum specific HCV antibodies in some of these patients was not informative because of the impairment in specific antibody production, the reverse transcriptase polymerase chain reaction (RT-PCR) assay used to detect serum HCV RNA was a useful method for diagnosing infection. We found that 38% of late onset hypogammaglobulinaemic patients (CVI, HIM or IgG subclass deficiency) had evidence of HCV infection. HCV infection was not detectable in patients with XLA or AT. The majority of our patients had persistent viraemia, and those who underwent liver biopsy showed histological findings of chronic hepatitis. Moreover, we could demonstrate in vitro that eight of 18 HCV-infected patients were actively producing anti-HCV antibodies, despite their impaired antibody production. The high rate of HCV infection in hypogammaglobulinaemic patients could be related to several nosocomial routes of transmission, including intravenous immune globulin administration. Despite the persistent viremia only two patients had cirrhosis and none had hepatocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554376      PMCID: PMC1553328          DOI: 10.1111/j.1365-2249.1995.tb06629.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Cytomegalovirus infection and common variable immunodeficiency.

Authors:  W D Döcke; H U Simon; E Fietze; S Prösch; C Diener; P Reinke; H Stein; H D Volk
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

2.  Hepatitis C virus antibodies in gammaglobulin.

Authors:  I Quinti; R Paganelli; E Scala; E Guerra; I Mezzaroma; G P D'Offizi; F Aiuti
Journal:  Lancet       Date:  1990-12-01       Impact factor: 79.321

3.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

4.  Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).

Authors:  M Chiaramonte; T Stroffolini; N Caporaso; R Coppola; A Craxì; G B Gaeta; E Sagnelli; A R Zanetti
Journal:  Ital J Gastroenterol       Date:  1991-12

5.  Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia.

Authors:  Y S Choi; W D Biggar; R A Good
Journal:  Lancet       Date:  1972-05-27       Impact factor: 79.321

6.  Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.

Authors:  J I Esteban; A González; J M Hernández; L Viladomiu; C Sánchez; J C López-Talavera; D Lucea; C Martin-Vega; X Vidal; R Esteban
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

7.  Prevalence of gallstones in patients with primary immunoglobulin deficiency. Evidence for lack of association.

Authors:  A De Santis; R Paganelli; R Stefanoni; A Di Sabatino; M Angelico
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

8.  Hypogammaglobulinemia associated with cytomegalovirus pneumonia.

Authors:  P A Greenberger; C L Walker; T E Fitzsimons; M Roberts
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

9.  Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver.

Authors:  K Hosoda; M Omata; O Yokosuka; N Kato; M Ohto
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

View more
  6 in total

Review 1.  Clinical immunology.

Authors:  T E Mollnes; M Harboe
Journal:  BMJ       Date:  1996-06-08

2.  HCV infection in a patient with hyper IgM syndrome.

Authors:  I Quinti; A Giovannetti; R Paganelli; L P Pucillo; A R Varani; G Ricci; E Scala; F Pandolfi; M Casato; F Aiuti
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

3.  A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency.

Authors:  Kultigin Turkmen; Melih Anil; Yalcin Solak; Huseyin Atalay; Hasan Esen; Halil Z Tonbul
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

4.  Sustained virologic response following HCV eradication in two brothers with X-linked agammaglobulinaemia.

Authors:  Diarmaid D Houlihan; Eoin R Storan; John M Lee
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

5.  Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.

Authors:  Federica Pulvirenti; Ilaria Pentassuglio; Cinzia Milito; Michele Valente; Adriano De Santis; Valentina Conti; Giulia d'Amati; Oliviero Riggio; Isabella Quinti
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

Review 6.  Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders.

Authors:  Antonio Pecoraro; Ludovica Crescenzi; Gilda Varricchi; Giancarlo Marone; Giuseppe Spadaro
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.